World's Best Scientists 2026 revealed!
Andrew H. Limper

Andrew H. Limper

D-Index & Metrics

Microbiology

D-Index
69
Citations
19805
World Ranking
2019
National Ranking
854

Overview

Andrew H. Limper is a researcher affiliated with the Mayo Clinic in the United States, specializing in the field of Medicine with a focus on Pulmonary and Respiratory Medicine. Their research encompasses several subfields including Epidemiology, Infectious Diseases, Immunology, and Oncology.

The main topics in their work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pneumocystis jirovecii pneumonia detection and treatment, Pneumonia and Respiratory Infections, Tuberculosis Research and Epidemiology, Antifungal resistance and susceptibility, Medical Imaging and Pathology Studies, and Occupational and environmental lung diseases.

Limper has contributed to numerous publications with notable recent papers such as:

  • Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023, EBioMedicine)
  • Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study (2022, The Lancet Respiratory Medicine)
  • Tissue-resident CD8 + T cells drive age-associated chronic lung sequelae after viral pneumonia (2020, Science Immunology)
  • Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis (2021, Annals of the American Thoracic Society)
  • IPF pathogenesis is dependent upon TGFβ induction of IGF-1 (2020, The FASEB Journal)

The scientist publishes frequently in venues such as bioRxiv (Cold Spring Harbor Laboratory), CHEST Journal, American Journal of Respiratory and Critical Care Medicine, Respiratory Research, and BMC Pulmonary Medicine.

Collaborations are a significant part of Limper's research efforts, with frequent coauthors including Theodore J. Kottom, Eva M. Carmona, Kyle Schaefbauer, Timothy Dempsey, and Lindsey R. Sangaralingham.

Best Publications

  • Medical progress: Pneumocystis pneumonia

    Charles F. Thomas;Andrew H. Limper

  • Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

    Craig E. Daniels;Mark C. Wilkes;Maryanne Edens;Ted J. Kottom

  • An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients

    Andrew H. Limper;Kenneth S. Knox;George A. Sarosi;Neil M. Ampel

  • Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy

    Steven H. Yale;Andrew H. Limper

  • Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS

    Andrew H. Limper;Kenneth P. Offord;Thomas F. Smith;William J. Martin

  • Pulmonary Langerhans'-cell histiocytosis.

    Robert Vassallo;Jay H. Ryu;Thomas V. Colby;Thomas Hartman

  • Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.

    Robert Vassallo;Jay H. Ryu;Darrell R. Schroeder;Paul A. Decker

  • Stretch induces cytokine release by alveolar epithelial cells in vitro.

    Nicholas E. Vlahakis;Mark A. Schroeder;Andrew H. Limper;Rolf D. Hubmayr

  • Fungal infections in HIV/AIDS

    Andrew H Limper;Antoine Adenis;Thuy Le;Thuy Le;Thomas S Harrison

  • Current insights into the biology and pathogenesis of Pneumocystis pneumonia

    Charles F. Thomas;Andrew H. Limper

  • The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung

    Andrew H. Limper;Jacques S. Hoyte;Joseph E. Standing

  • Chemotherapy-induced lung disease

    Andrew H Limper

  • Multiple TLRs Are Expressed in Human Cholangiocytes and Mediate Host Epithelial Defense Responses to Cryptosporidium parvum via Activation of NF-κB

    Xian Ming Chen;Steven P. O'Hara;Jeremy B. Nelson;Patrick L. Splinter

  • Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features.

    Emir Festic;Ognjen Gajic;Andrew H Limper;Timothy R Aksamit

  • Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.

    Deirdre M. O'Riordan;Joseph E. Standing;Kun Young Kwon;Donald Chang

  • Update on the Diagnosis and Treatment of Pneumocystis Pneumonia

    Eva M. Carmona;Andrew H. Limper

  • Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline

    Chadi A Hage;Eva M Carmona;Oleg Epelbaum;Scott E Evans

  • Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses

    Robert Vassallo;Joseph E. Standing;Andrew H. Limper

  • Pneumocystis carinii Cell Wall β-Glucan Induces Release of Macrophage Inflammatory Protein-2 from Alveolar Epithelial Cells via a Lactosylceramide-mediated Mechanism

    Peter Y. Hahn;Scott E. Evans;Theodore J. Kottom;Joseph E. Standing

  • Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture

    R. T. Hayden;J. R. Uhl;X. Qian;M. K. Hopkins

  • The Overlap Between Respiratory Bronchiolitis and Desquamative Interstitial Pneumonia in Pulmonary Langerhans Cell Histiocytosis: High-Resolution CT, Histologic, and Functional Correlations

    Robert Vassallo;Eric A. Jensen;Thomas V. Colby;Jay H. Ryu

  • Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism.

    O A Hoffman;J E Standing;A H Limper

  • An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP)

    Laurence Huang;Alison Morris;Andrew H. Limper;James M. Beck

Frequent Co-Authors

Edward B. Leof
Edward B. Leof Mayo Clinic
Jay H. Ryu
Jay H. Ryu Mayo Clinic
Ping Yang
Ping Yang Mayo Clinic
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Thomas V. Colby
Thomas V. Colby Mayo Clinic
Frank C. Sciurba
Frank C. Sciurba University of Pittsburgh
Marvin I. Schwarz
Marvin I. Schwarz University of Colorado Denver
Peter B. Bitterman
Peter B. Bitterman University of Minnesota
Hongfang Liu
Hongfang Liu The University of Texas Health Science Center at Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open doors to diverse career opportunities. Many aspiring healthcare professionals consider medical degrees online to gain a flexible education that complements their interest in biological sciences.

Public health is another complementary field, with numerous online MPH programs easy to get into available. These programs often appeal to microbiology graduates who want to impact community health through epidemiology or infectious disease control.

Beyond traditional science roles, careers such as child life specialists offer unique paths combining healthcare knowledge with emotional support for young patients. Understanding the child life specialists salary and job outlook can help students decide if this specialty aligns with their goals.

It's also important to consider accessibility in higher education. Various online colleges that accept felons provide opportunities for individuals with past convictions to rebuild careers in science and healthcare fields. This inclusivity highlights the expanding range of options for motivated learners.

Best Scientists Citing Andrew H. Limper

Trending Scientists